Is ensifentrine-Ohtuvayre available in the country and how to purchase it formally?

Ensifentine (Ensifentrine), trade nameOhtuvayre, is a new dual phosphodiester Enzyme inhibitors (PDE3/4inhibitors) are used to treat bronchodilation and improve respiratory function in patients with chronic obstructive pulmonary disease (COPD). At present, exefantine has not been launched in mainland China, nor has it been included in the medical insurance reimbursement system, so domestic patients cannot purchase the drug directly through regular hospital pharmacies.

For patients who want to use exefantine, the current main way is overseas legal channels. The US versionOhtuvayre is available in some pharmacies in Hong Kong, with the specification of 3mg/2.5mL (60doses), priced at approximately 44,500 Hong Kong dollars/ boxes. The price is higher and will be affected by exchange rate fluctuations. When purchasing, you must ensure that the channels are legal, the source of the medicine is reliable, and you have a valid prescription to ensure the quality and safety of the medicine.

Since there is no domestic marketing channel, patients who obtain drugs through cross-border purchase need to pay attention to laws, regulations and transportation compliance. It is recommended to purchase drugs through formal medical institutions, certified international pharmacies or cross-border medical service platforms, and avoid obtaining drugs through informal drug purchasing platforms or personal channels to prevent counterfeit drugs, expired drugs or improper transportation from reducing drug efficacy.

Generally speaking, the accessibility of exefantine in China is limited. If patients need it, they should communicate the treatment plan with their attending doctor in advance and make arrangements through legal overseas drug purchase channels. At the same time, you must follow medical advice during purchase and use, and conduct necessary efficacy monitoring and adverse reaction observation to ensure treatment safety and maximum efficacy.

Reference link:https://www.drugs.com